What does CUSIP 05464T104 represent in this 13F holders report?

CUSIP 05464T104 is the security identifier for AXSM - Axsome Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AXSM - Axsome Therapeutics, Inc. - Common Stock in Q2 2022?

164 institutional investors reported AXSM - Axsome Therapeutics, Inc. - Common Stock for Q2 2022. Use the holders table for investor-level position and value details.

Axsome Therapeutics, Inc. - Common Stock (AXSM)

CUSIP: 05464T104

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock
Shares outstanding: 48,932,355
Total 13F shares: 21,590,557
Share change: +2,530,605
Total reported value: $826,608,565
Put/Call ratio: 102%
Price per share: $38.30
Number of holders: 164
Value change: +$90,967,881
Number of buys: 87
Number of sells: 64

Quarterly Holders Quick Answers

What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 05464T104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	5.5%	2,699,490	$111,730,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	4.3%	2,092,257	$86,600,000	—	31 Mar 2022	13F
RTW INVESTMENTS, LP	13F	Company	3.3%	1,618,819	$67,003,000	—	31 Mar 2022	13F
ALETHEA CAPITAL MANAGEMENT, LLC	13F	Company	2.1%	1,043,159	$43,176,000	—	31 Mar 2022	13F
Fairmount Funds Management LLC	13F	Company	1.9%	942,571	$39,013,000	—	31 Mar 2022	13F
Bellevue Group AG	13F	Company	1.5%	719,482	$29,779,000	—	31 Mar 2022	13F
Avidity Partners Management LP	13F	Company	1.5%	711,000	$29,428,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	1.4%	699,006	$28,932,000	—	31 Mar 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.3%	650,000	$26,904,000	—	31 Mar 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	1.2%	610,970	$25,288,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	536,024	$22,186,000	—	31 Mar 2022	13F
IRIDIAN ASSET MANAGEMENT LLC/CT	13F	Company	1.1%	517,580	$21,423,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.86%	422,680	$14,075,000	—	31 Mar 2022	13F
GROUP ONE TRADING LLC	13F	Company	0.62%	303,773	$12,573,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.57%	280,700	$11,618,000	—	31 Mar 2022	13F
WMS Partners, LLC	13F	Company	0.5%	242,500	$10,037,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.48%	237,013	$9,810,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.47%	230,912	$9,557,000	—	31 Mar 2022	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.44%	215,219	$8,908,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.44%	213,213	$8,825,000	—	31 Mar 2022	13F
MANGROVE PARTNERS IM, LLC	13F	Company	0.37%	181,695	$7,520,000	—	31 Mar 2022	13F
PICTET ASSET MANAGEMENT SA	13F	Company	0.37%	181,672	$7,519,000	—	31 Mar 2022	13F
NORGES BANK	13F	Company	0.36%	177,280	$7,337,619	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.36%	176,086	$7,288,000	—	31 Mar 2022	13F
PEREGRINE CAPITAL MANAGEMENT LLC	13F	Company	0.34%	165,656	$6,857,000	—	31 Mar 2022	13F
Caption Management, LLC	13F	Company	0.32%	157,500	$6,519,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.32%	155,392	$6,432,000	—	31 Mar 2022	13F
SEI INVESTMENTS CO	13F	Company	0.3%	146,363	$6,059,000	—	31 Mar 2022	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.03%	14,000	$5,402,000	—	31 Mar 2022	13F
WCM INVESTMENT MANAGEMENT, LLC	13F	Company	0.26%	128,692	$5,323,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	0.25%	123,016	$5,092,000	—	31 Mar 2022	13F
S.c.a. Candriam	13F	Individual	0.24%	115,084	$4,763,000	—	31 Mar 2022	13F
MORGAN JESS S & CO INC	13F	Company	0.22%	107,187	$4,436,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.22%	105,423	$4,364,000	—	31 Mar 2022	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.21%	105,137	$4,352,000	—	31 Mar 2022	13F
Graham Capital Management, L.P.	13F	Company	0.21%	101,851	$4,215,000	—	31 Mar 2022	13F
Endurant Capital Management LP	13F	Company	0.2%	100,299	$4,151,000	—	31 Mar 2022	13F
MPM BioImpact LLC	13F	Company	0.2%	99,834	$4,132,000	—	31 Mar 2022	13F
Ghost Tree Capital, LLC	13F	Company	0.19%	94,500	$3,911,000	—	31 Mar 2022	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.16%	77,967	$3,227,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.12%	58,137	$2,406,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.12%	58,000	$2,401,000	—	31 Mar 2022	13F
BALDWIN WEALTH PARTNERS LLC/MA	13F	Company	0.11%	54,845	$2,270,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.11%	52,874	$2,188,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.1%	48,529	$2,009,000	—	31 Mar 2022	13F
CREDIT SUISSE AG/	13F	Company	0.09%	46,156	$1,911,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.09%	45,315	$1,876,000	—	31 Mar 2022	13F
Employees Retirement System of Texas	13F	Company	0.09%	42,000	$1,738,000	—	31 Mar 2022	13F
JANE STREET GROUP, LLC	13F	Company	0.08%	40,559	$1,679,000	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.08%	40,000	$1,656,000	—	31 Mar 2022	13F

Institutional Holders of Axsome Therapeutics, Inc. - Common Stock (AXSM) as of Q2 2022

As of 30 Jun 2022, Axsome Therapeutics, Inc. - Common Stock (AXSM) was held by 164 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,590,557 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., RTW INVESTMENTS, LP, PFM Health Sciences, LP, Fairmount Funds Management LLC, STATE STREET CORP, Bellevue Group AG, ALETHEA CAPITAL MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., and Nuveen Asset Management, LLC. This page lists 165 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

165

Q2 2022 holders

164

Holder diff

-1

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.